H11I official logo

H11I intelligence agent

H11-PHARMA

Pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence

Unique intelligence

The Pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence. Its non-interchangeable governed contract covers pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology; it emits a typed artifact for H11-SIM synthesis and cannot substitute for H11-SCIENTIA's scientific-method authority or another agent's release gate.

Intelligence planeKnowledge
Agent categorypharmaceutical-intelligence
Sovereign modelH11-SIM

Role in the council

Pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence

This specialist contributes to adaptive H11I councils while evidence, authority, verification, and execution remain separated by platform governance.

Platform engine contract

H11-SIM activates H11-PHARMA when the present user intent requires pharmacology, medicinal chemistry, drug discovery, pharmacokinetics, toxicology, and therapeutic-development intelligence; the result is used as one verified contribution inside the 110-agent council rather than as a standalone chatbot reply.

Runtime pipeline

  1. lock the relevant user intent and success condition
  2. build the agent-specific task frame
  3. target-mechanism mapping
  4. dose-exposure-response modeling
  5. interaction and toxicity analysis
  6. development-evidence gating
  7. emit typed artifacts with uncertainty and failure flags
  8. hand off to H11I-VERITAS / H11I-ZENITH for release synthesis

Typed artifacts

Quality gates

Authority boundary: bounded specialist analysis and typed recommendation; no independent external authority

Failure recovery: Return the failed gate, preserve the strongest verified partial result, and request escalation/revision instead of inventing certainty.

Source backing